南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

源自人乳的二乙基乳糖-N-四糖通过抑制PI3K/AKT介导的巨噬细胞促炎激活,有效预防坏死性小肠炎的发生。

Human milk-derived disialyllacto-N-tetraose protects against necrotizing enterocolitis by suppressing PI3K/AKT-mediated macrophage pro-inflammatory activation

Wenwei Jiang, Minyan Qian, Jinling Mo, Jiamin Dong, Dan Wang, Dong Zhou, Wenting Zhang

Journal:Journal of Functional Foods

IF:3.9

DOI:10.1016/j.jff.2026.107507

PMID:

Published:2026-09-12

research field:毒理学细胞生物学免疫学代谢组学环境健康

Abstract

Among ten HMOs, DSLNT is lower in NEC breast milk, reinforcing its biomarker role. • Integrative network analysis, molecular docking and 100 ns MD reveal PI3K/AKT as DSLNT target. • DSLNT inhibits macrophage oxidative stress, mitochondrial dysfunction, iNOS, p-AKT; reversed by 740Y-P via PI3K/AKT. Necrotizing enterocolitis (NEC) remains a leading cause of morbidity and mortality in preterm infants, and human milk oligosaccharides (HMOs) have emerged as bioactive components implicated in its prevention. Although reduced disialyllacto-N-tetraose (DSLNT) in maternal milk has been linked to NEC risk, the molecular mechanism by which DSLNT modulates intestinal inflammation remains poorly defined. UPLC-MS/MS quantification of ten representative HMOs in milk from mothers of full-term, preterm, and NEC infants revealed a reduction of DSLNT in the NEC group. An integrated strategy combining network pharmacology, KEGG enrichment analysis, molecular docking, and molecular dynamics simulations predicted the PI3K/AKT signaling pathway as a potential target of DSLNT. Functional validation in LPS/IFN-γ-stimulated RAW 264.7 macrophages demonstrated that DSLNT inhibited pro-inflammatory activation, alleviated oxidative stress, stabilized mitochondrial function, and suppressed iNOS expression as well as AKT phosphorylation; these protective effects were abrogated by the PI3K agonist 740Y-P. Mechanistic dissection further confirmed that DSLNT suppresses the activation of the PI3K/AKT pathway, thereby downregulating the expression of inflammatory mediators. Collectively, these findings support that DSLNT attenuates the inflammatory response through inhibition of the PI3K/AKT pathway in macrophages, providing a mechanistic rationale for its further evaluation as a therapeutic candidate. This study elucidates the protective mechanism of DSLNT against NEC by employing a comprehensive computational strategy to identify candidate targets and pathways. Systems pharmacology analysis first r

本文使用的Yeasen产品

购物车
客服
转染试用